1887

Journal of General Virology header logo

Volume 103, Issue 6

CD137 costimulation is associated with reduced herpetic stromal keratitis and with developing normal CD8 T cells in trigeminal ganglia No Access

Abstract

Costimulatory interactions can be critical in developing immune responses to infectious agents. We recently reported that herpes simplex type 1 (HSV-1) infections of the cornea require a functional CD28-CD80/86 interaction to not only reduce the likelihood of encephalitis, but also to mediate herpetic stromal keratitis (HSK) following viral reactivation. In this same spirit we decided to determine the role that CD137 costimulation plays during HSK. Using both B6-CD137L mice, as well as antagonistic and agonistic antibodies to CD137 we characterize the immune response and to what extent CD137 plays an important role during this disease. Immune responses were measured in both the cornea and in the trigeminal ganglia where the virus forms a latent infection. We demonstrate that CD137 costimulation leads to reduced corneal disease. Interestingly, we observed that lack of CD137 costimulation resulted in significantly reduced CD8 T expansion and function in the trigeminal ganglia. Finally, we showed that viruses that have been genetically altered to express CD137 display significantly reduced corneal disease, though they did present similar levels of trigeminal infection and peripheral virus production following reactivation of a latent infection. CD137 interactions lead to reduced HSK and are necessary to develop robust trigeminal CD8 T cell responses.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): CD137 costimulation , herpes simplex , pathogenesis and recombinant virus
Funding
This study was supported by the:
  • National Institutes of Health (Award EY026071)
    • Principle Award Recipient: PatrickMichael Stuart
© 2022 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001756
2022-06-29
2024-04-26
Loading full text...

Full text loading...

References

  1. Tuli SS. Herpes simplex keratitis. In Yanoff JS, Duker M. eds Ophthalmology, 3rd ed. Elsevier Inc; 2009
     [Google Scholar]
  2. Preston CM. Repression of viral transcription during herpes simplex virus latency. J Gen Virol 2000; 81:1–19 [View Article] [PubMed]
     [Google Scholar]
  3. Summers BC, Margolis TP, Leib DA. Herpes simplex virus type 1 corneal infection results in periocular disease by zosteriform spread. J Virol 2001; 75:5069–5075 [View Article] [PubMed]
     [Google Scholar]
  4. Feldman LT, Ellison AR, Voytek CC, Yang L, Krause P et al. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A 2002; 99:978–983 [View Article] [PubMed]
     [Google Scholar]
  5. Cunningham AL, Diefenbach RJ, Miranda-Saksena M, Bosnjak L, Kim M et al. The cycle of human herpes simplex virus infection: virus transport and immune control. J Infect Dis 2006; 194 Suppl 1:S11–8 [View Article] [PubMed]
     [Google Scholar]
  6. Knipe DM, Cliffe A. Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol 2008; 6:211–221 [View Article] [PubMed]
     [Google Scholar]
  7. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review. J Infect Dis 2002; 186 Suppl 1:S3–28 [View Article] [PubMed]
     [Google Scholar]
  8. Umene K, Sakaoka H. Evolution of herpes simplex virus type 1 under herpesviral evolutionary processes. Arch Virol 1999; 144:637–656 [View Article] [PubMed]
     [Google Scholar]
  9. Liang Y, Vogel JL, Narayanan A, Peng H, Kristie TM. Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat Med 2009; 15:1312–1317 [View Article] [PubMed]
     [Google Scholar]
  10. Shimeld C, Hill TJ, Blyth B, Easty D. An improved model of recurrent herpetic eye disease in mice. Curr Eye Res 1989; 8:1193–1205 [View Article] [PubMed]
     [Google Scholar]
  11. Shimeld C, Hill TJ, Blyth WA, Easty DL. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system. J Gen Virol 1990; 71 (Pt 3):681–687 [View Article] [PubMed]
     [Google Scholar]
  12. Farooq AV, Shukla D. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol 2012; 57:448–462 [View Article] [PubMed]
     [Google Scholar]
  13. Azher TN, Yin XT, Tajfirouz D, Huang AJH, Stuart PM. Herpes simplex keratitis: challenges in diagnosis and clinical management. Clin Ophthalmol 2017; 11:185–191 [View Article] [PubMed]
     [Google Scholar]
  14. Rowe AM, St Leger AJ, Jeon S, Dhaliwal DK, Knickelbein JE et al. Herpes keratitis. Prog Retin Eye Res 2013; 32:88–101 [View Article] [PubMed]
     [Google Scholar]
  15. Tuli S, Sonal S et al. Herpes Simplex Keratitis. In Yanoff JS, Duker M, Wiggs JL, Miller D, Azar DT. eds Ophthalmology, 3rd ed. Elsevier Inc; 2009
     [Google Scholar]
  16. Divito SJ, Hendricks RL. Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis. Invest Ophthalmol Vis Sci 2008; 49:1488–1495 [View Article] [PubMed]
     [Google Scholar]
  17. Duan R, Remeijer L, van Dun JM, Osterhaus ADME, Verjans GMGM. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK. Invest Ophthalmol Vis Sci 2007; 48:277–284 [View Article] [PubMed]
     [Google Scholar]
  18. Russell RG, Nasisse MP, Larsen HS, Rouse BT. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest Ophthalmol Vis Sci 1984; 25:938–944 [PubMed]
     [Google Scholar]
  19. Newell CK, Martin S, Sendele D, Mercadal CM, Rouse BT. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J Virol 1989; 63:769–775 [View Article] [PubMed]
     [Google Scholar]
  20. Doymaz MZ, Rouse BT. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes. Invest Ophthalmol Vis Sci 1992; 33:2165–2173 [PubMed]
     [Google Scholar]
  21. Keadle TL, Morris JL, Pepose JS, Stuart PM. CD4(+) and CD8(+) cells are key participants in the development of recurrent herpetic stromal keratitis in mice. Microb Pathog 2002; 32:255–262 [View Article] [PubMed]
     [Google Scholar]
  22. Yin X-T, Baugnon NK, Potter CA, Tai S, Keadle TL et al. CD28 Costimulation Is Required for Development of Herpetic Stromal Keratitis but Does Not Prevent Establishment of Latency. J Virol 2019; 93:e00659-19 [View Article] [PubMed]
     [Google Scholar]
  23. Xu M, Lepisto AJ, Hendricks RL. CD154 signaling regulates the Th1 response to herpes simplex virus-1 and inflammation in infected corneas. J Immunol 2004; 173:1232–1239 [View Article] [PubMed]
     [Google Scholar]
  24. Lepisto AJ, Xu M, Yagita H, Weinberg AD, Hendricks RL. Expression and function of the OX40/OX40L costimulatory pair during herpes stromal keratitis. J Leukoc Biol 2007; 81:766–774 [View Article] [PubMed]
     [Google Scholar]
  25. Seo SK, Park HY, Choi JH, Kim WY, Kim YH et al. Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis. J Immunol 2003; 171:576–583 [View Article] [PubMed]
     [Google Scholar]
  26. Shuford WW, Klussman K, Tritchler DD, Loo DT, Chalupny J et al. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med 1997; 186:47–55 [View Article] [PubMed]
     [Google Scholar]
  27. Lee HW, Nam KO, Park SJ, Kwon BS. 4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D and E and cyclin-dependent kinase inhibitor p27kip1. Eur J Immunol 2003; 33:2133–2141 [View Article] [PubMed]
     [Google Scholar]
  28. Robertson SJ, Messer RJ, Carmody AB, Mittler RS, Burlak C et al. CD137 costimulation of CD8+ T cells confers resistance to suppression by virus-induced regulatory T cells. J Immunol 2008; 180:5267–5274 [View Article] [PubMed]
     [Google Scholar]
  29. Lee S, Mittler RS, Moore ML. Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice. J Immunol 2014; 192:293–299 [View Article] [PubMed]
     [Google Scholar]
  30. Welten SPM, Redeker A, Franken KLMC, Oduro JD, Ossendorp F et al. The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion. Elife 2015; 4: [View Article] [PubMed]
     [Google Scholar]
  31. Lin GHY, Sedgmen BJ, Moraes TJ, Snell LM, Topham DJ et al. Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease. J Immunol 2009; 182:934–947 [View Article] [PubMed]
     [Google Scholar]
  32. Zhang X, Voskens CJ, Sallin M, Maniar A, Montes CL et al. CD137 promotes proliferation and survival of human B cells. J Immunol 2010; 184:787–795 [View Article] [PubMed]
     [Google Scholar]
  33. Stuart PM, Summers B, Morris JE, Morrison LA, Leib DA. CD8+ T cells control corneal disease following ocular infection with herpes simplex virus type 1. J Gen Virol 2004; 85:2055–2063 [View Article] [PubMed]
     [Google Scholar]
  34. Keadle TL, Morrison LA, Morris JL, Pepose JS, Stuart PM. Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection. J Virol 2002; 76:3615–3625 [View Article] [PubMed]
     [Google Scholar]
  35. Royer DJ, Gurung HR, Jinkins JK, Geltz JJ, Wu JL et al. A highly efficacious herpes simplex virus 1 vaccine blocks viral pathogenesis and prevents corneal immunopathology via humoral immunity. J Virol 2016; 90:5514–5529 [View Article] [PubMed]
     [Google Scholar]
  36. Petro CD, Weinrick B, Khajoueinejad N, Burn C, Sellers R et al. HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates. JCI Insight 2016; 1:e88529 [View Article] [PubMed]
     [Google Scholar]
  37. Umeshappa CS, Huang H, Xie Y, Wei Y, Mulligan SJ et al. CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses. J Immunol 2009; 182:193–206 [View Article] [PubMed]
     [Google Scholar]
  38. Frank GM, Buela K-AG, Maker DM, Harvey SAK, Hendricks RL. Early responding dendritic cells direct the local NK response to control herpes simplex virus 1 infection within the cornea. J Immunol 2012; 188:1350–1359 [View Article] [PubMed]
     [Google Scholar]
  39. Yun H, Yee MB, Lathrop KL, Kinchington PR, Hendricks RL et al. Production of the cytokine VEGF-A by CD4+ T and myeloid cells disrupts the corneal nerve landscape and promotes herpes stromal keratitis. Immunity 2020; 53:1050–1062 [View Article] [PubMed]
     [Google Scholar]
  40. Summers BC, Leib DA. Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters. J Virol 2002; 76:7020–7029 [View Article] [PubMed]
     [Google Scholar]
  41. Zhang H, Knutson KL, Hellstrom KE, Disis ML, Hellstrom I. Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv-expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusion. Mol Cancer Ther 2006; 5:149–155 [View Article] [PubMed]
     [Google Scholar]
  42. West DM, Del Rosso CR, Yin X-T, Stuart PM. CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis. J Immunol 2014; 192:1762–1767 [View Article] [PubMed]
     [Google Scholar]
  43. Miller JK, Laycock KA, Nash MM, Pepose JS. Corneal Langerhans cell dynamics after herpes simplex virus reactivation. Invest Ophthalmol Vis Sci 1993; 34:2282–2290 [PubMed]
     [Google Scholar]
  44. Miller JK, Laycock KA, Umphress JA, Hook KK, Stuart PM et al. A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice. Cornea 1996; 15:497–504 [PubMed]
     [Google Scholar]
  45. Bauer D, Mrzyk S, van Rooijen N, Steuhl KP, Heiligenhaus A. Macrophage-depletion influences the course of murine HSV-1 keratitis. Curr Eye Res 2000; 20:45–53 [PubMed]
     [Google Scholar]
  46. Kohrt HE, Houot R, Weiskopf K, Goldstein MJ, Scheeren F et al. Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer. J Clin Invest 2012; 122:1066–1075 [View Article] [PubMed]
     [Google Scholar]
  47. Kohrt HE, Colevas AD, Houot R, Weiskopf K, Goldstein MJ et al. Targeting CD137 enhances the efficacy of cetuximab. J Clin Invest 2014; 124:2668–2682 [View Article] [PubMed]
     [Google Scholar]
  48. Dharmadhikari B, Nickles E, Harfuddin Z, Ishak NDB, Zeng Q et al. CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8+ T cells to Tc1 phenotype. Cancer Immunol Immunother 2018; 67:893–905 [View Article] [PubMed]
     [Google Scholar]
  49. Pei Y, Wen K, Xiang Z, Huang C, Wang X et al. CD137 costimulation enhances the antiviral activity of Vγ9Vδ2-T cells against influenza virus. Signal Transduct Target Ther 2020; 5:74 [View Article] [PubMed]
     [Google Scholar]
  50. Shin SM, Kim YH, Choi BK, Kwon PM, Lee HW et al. 4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation. J Leukoc Biol 2007; 81:1455–1465 [View Article] [PubMed]
     [Google Scholar]
  51. Banerjee K, Biswas PS, Rouse BT. Role of Stat4-mediated signal transduction events in the generation of aggressor CD4+ T cells in herpetic stromal keratitis pathogenesis. J Interferon Cytokine Res 2007; 27:65–75 [View Article] [PubMed]
     [Google Scholar]
  52. Rajasagi NK, Rouse BT. The Role of T Cells in Herpes Stromal Keratitis. Front Immunol 2019; 10:512 [View Article] [PubMed]
     [Google Scholar]
  53. Rodriguez R, Fournier B, Cordeiro DJ, Winter S, Izawa K et al. Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells. J Exp Med 2019; 216:2800–2818 [View Article]
     [Google Scholar]
  54. St Leger AJ, Hendricks RL. CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation. J Neurovirol 2011; 17:528–534 [View Article] [PubMed]
     [Google Scholar]
  55. St Leger AJ, Jeon S, Hendricks RL. Broadening the repertoire of functional herpes simplex virus type 1-specific CD8+ T cells reduces viral reactivation from latency in sensory ganglia. J Immunol 2013; 191:2258–2265 [View Article] [PubMed]
     [Google Scholar]
  56. Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med 2011; 365:725–733 [View Article] [PubMed]
     [Google Scholar]
  57. Navabi S sadat, Doroudchi M, Tashnizi AH, Habibagahi M. Natural Killer Cell Functional Activity After 4-1BB Costimulation. Inflammation 2015; 38:1181–1190 [View Article] [PubMed]
     [Google Scholar]
  58. Yoshimori M, Imadome K-I, Komatsu H, Wang L, Saitoh Y et al. CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signals. PLoS One 2014; 9:e112564 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001756
Loading
CD137 costimulation is associated with reduced herpetic stromal keratitis and with developing normal CD8+ T cells in trigeminal ganglia
J. Gen. Virol. 103, 001756 (2022); https://doi.org/10.1099/jgv.0.001756
/content/journal/jgv/10.1099/jgv.0.001756
/content/journal/jgv/10.1099/jgv.0.001756
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error